Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Ligandal

Main focus: Novel delivery technologies

Company stage: Pre-clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: San Francisco, CA, US

Website: https://www.ligandal.com/

Ligandal is a US-based, privately held biotech company focused on improving delivery systems for gene therapies. Ligandal creates bioinspired nanomaterials that more effectively deliver CRISPR reagents into the nucleus of T cells, which is the company's main target cell. The nanomaterials are developed from ligand-binding motifs derived from natural proteins interacting with the protein of interest.

Tags

HashtagLigandal Inc.

Company: Ligandal
close
Search CRISPR Medicine